Publikationen

Zeitschriftenveröffentlichungen

  • Esubalew ST, Tadesse S, Shibeshi AB, Engidawork E, Schaufler K, Guenther S, Asres K. Screening of Twenty-one Ethiopian Medicinal Plants for their Antiproliferative Activity against Human Acute Myeloid Leukemia (MV4-11) Cell Line. Ethiopian Pharmaceutical Journal. 2019. 35:143-148.
  • Schierack P, Heiden SE, Khan MM, Nikolaus L, Kolenda R, Stubbe M, Lkhagvasuren D, Rödiger S, Guenther S, Schaufler K. Genomic and Phenotypic Analysis of an ESBL-Producing E. coli ST1159 Clonal Lineage From Wild Birds in Mongolia. Front Microbiol. 2020. 11:1699.
  • Barth SA, Weber M, Schaufler K, Berens C, Geue L, Menge C. Metabolic Traits of Bovine Shiga Toxin-Producing Escherichia coli (STEC) Strains with Different Colonization Properties. Toxins (Basel). 2020. 12(6):E414.
  • Prehn F, Timmermann E, Kettlitz M, Schaufler K, Guenther S, Hahn V. Inactivation of airborne bacteria by plasma treatment and ionic wind for indoor air cleaning. Plasma Process Polym. 2020. e2000027.
  • Heiden SE, Kurz MSE, Bohnert J, Bayingana C, Ndoli JM, Sendegeya A, Gahutu JB, Eger E, Mockenhaupt FP, Schaufler K. Flies from a tertiary hospital in Rwanda carry multidrug-resistant Gram-negative pathogens including extended-spectrum beta-lactamase-producing E. coli sequence type 131. Antimicrob Resist Infect Control. 2020. 9(1):34.
  • Haller S, Kramer R, Becker K, Bohnert JA, Eckmanns T, Hans JB, Hecht J, Heidecke CD, Hübner NO, Kramer A, Klaper K, Littmann M, Marlinghaus L, Neumann B, Pfeifer Y, Pfennigwerth N, Rogge S, Schaufler K, Thürmer A, Werner G, Gatermann S. Extensively drug-resistant Klebsiella pneumoniae ST307 outbreak, north-eastern Germany, June to October 2019. Euro Surveill. 2019. 24(50):1900734.
  • Schaufler K, Semmler T, Wieler LH, Trott DJ, Pitout J, Peirano G, Bonnedahl J, Dolejska M, Literak I, Fuchs S, Ahmed N, Grobbel M, Torres C, McNally A, Pickard D, Ewers C, Croucher NJ, Corander J, Guenther S. Genomic and functional analysis of emerging virulent and multi-drug resistant E. coli lineage ST648. Antimicrob Agents Chemother. 2019. 63(6):e00243-19.
  • Ranjan A, Scholz J, Semmler T, Wieler LH, Ewers C, Müller S, Pickard DJ, Schierack P, Tedin K, Ahmed N, Schaufler K, Guenther S. ESBL-plasmid carriage in E. coli enhances in vitro bacterial competition fitness and serum resistance in some strains of pandemic sequence types without overall fitness cost. Gut Pathog. 2018. 10:24.
  • Schaufler K, Nowak K, Düx A, Semmler T, Villa L, Kourouma L, Bangoura K, Wieler LH, Leendertz FH, Guenther S. Clinically Relevant ESBL-Producing K. pneumoniae ST307 and E. coli ST38 in an Urban West African Rat Population. Front Microbiol. 2018. 9:150.
  • Mohsin M, Raza S, Schaufler K, Roschanski N, Sarwar F, Semmler T, Schierack P, Guenther S. High Prevalence of CTX-M-15-Type ESBL-Producing E. coli from Migratory Avian Species in Pakistan. Front Microbiol. 2017. 8:2476.
  • Shubin M, Schaufler K, Tedin K, Vehkala M, Corander J. Identifying Multiple Potential Metabolic Cycles in Time-Series from Biolog Experiments. PLoS One. 2016. 11(9):e0162276.
  • McNally A, Oren Y, Kelly D, Pascoe B, Dunn S, Sreecharan T, Vehkala M, Välimäki N, Prentice MB, Ashour A, Avram O, Pupko T, Dobrindt U, Literak I, Guenther S, Schaufler K, Wieler LH, Zhiyong Z, Sheppard SK, McInerney JO, Corander J. Combined Analysis of Variation in Core, Accessory and Regulatory Genome Regions Provides a Super-Resolution View into the Evolution of Bacterial Populations. PLoS Genet. 2016. 12(9):e1006280.
  • Mohsin M, Raza S, Roschanski N, Schaufler K, Guenther S. First description of plasmid-mediated colistin-resistant extended-spectrum β-lactamase-producing Escherichia coli in a wild migratory bird from Asia. Int J Antimicrob Agents. 2016. 48(4):463-4.
  • Schaufler K, Semmler T, Pickard DJ, de Toro M, de la Cruz F, Wieler LH, Ewers C, Guenther S. Carriage of Extended-Spectrum Beta-Lactamase-Plasmids Does Not Reduce Fitness but Enhances Virulence in Some Strains of Pandemic E. coli Lineages. Front Microbiol. 2016. 7:336.
  • Barreto Miranda I, Ignatius R, Pfüller R, Friedrich-Jänicke B, Steiner F, Paland M, Dieckmann S, Schaufler K, Wieler LH, Guenther S, Mockenhaupt FP. High carriage rate of ESBL-producing Enterobacteriaceae at presentation and follow-up among travellers with gastrointestinal complaints returning from India and Southeast Asia. J Travel Med. 2016. 23(2):tav024.
  • Schaufler K, Semmler T, Wieler LH, Wöhrmann M, Baddam R, Ahmed N, Müller K, Kola A, Fruth A, Ewers C, Guenther S. Clonal spread and interspecies transmission of clinically relevant ESBL-producing Escherichia coli of ST410—another successful pandemic clone?FEMS Microbiol Ecol. 2016. 92(1).
  • Rödiger S, Kramer T, Frömmel U, Weinreich J, Roggenbuck D, Guenther S, Schaufler K, Schröder C, Schierack P. Intestinal Escherichia coli colonization in a mallard duck population over four consecutive winter seasons. Environ Microbiol. 2015. 17(9):3352-61.
  • Schaufler K, Bethe A, Lübke-Becker A, Ewers C, Kohn B, Wieler LH, Guenther S. Putative connection between zoonotic multiresistant extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in dog feces from a veterinary campus and clinical isolates from dogs. Infect Ecol Epidemiol. 2015. 5:25334.
  • Ewers C, Bethe A, Stamm I, Grobbel M, Kopp PA, Guerra B, Stubbe M, Doi Y, Zong Z, Kola A, Schaufler K, Semmler T, Fruth A, Wieler LH, Guenther S. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?J Antimicrob Chemother. 2014. 69(5):1224-30.
  • Schaufler K, Wieler LH, Semmler T, Ewers C, Guenther S. ESBL-plasmids carrying toxin-antitoxin systems can be "cured" of wild-type Escherichia coli using a heat technique. Gut Pathog. 2013. 5(1):34.
  • Guenther S, Wuttke J, Bethe A, Vojtech J, Schaufler K, Semmler T, Ulrich RG, Wieler LH, Ewers C. Is fecal carriage of extended-spectrum-β-lactamase-producing Escherichia coli in urban rats a risk for public health?Antimicrob Agents Chemother. 2013. 57(5):2424-5.